Quantbot Technologies LP Boosts Stake in Maximus, Inc. $MMS

Quantbot Technologies LP raised its stake in shares of Maximus, Inc. (NYSE:MMS) by 146.3% during the second quarter, Holdings Channel.com reports. The institutional investor owned 43,863 shares of the health services provider’s stock after buying an additional 26,055 shares during the period. Quantbot Technologies LP’s holdings in Maximus were worth $3,079,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in MMS. Fuller & Thaler Asset Management Inc. lifted its position in shares of Maximus by 40.0% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock valued at $117,921,000 after acquiring an additional 494,372 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Maximus by 20.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock worth $115,620,000 after purchasing an additional 288,990 shares in the last quarter. AQR Capital Management LLC raised its stake in Maximus by 177.2% in the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after purchasing an additional 750,031 shares during the last quarter. Reinhart Partners LLC. lifted its holdings in Maximus by 0.3% in the 2nd quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider’s stock valued at $64,154,000 after purchasing an additional 2,345 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Maximus during the 2nd quarter worth about $47,886,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on MMS shares. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Maximus presently has an average rating of “Moderate Buy” and a consensus price target of $90.00.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the sale, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This trade represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Maximus Trading Down 0.5%

Shares of MMS stock opened at $84.44 on Friday. The firm’s 50-day simple moving average is $85.50 and its 200-day simple moving average is $80.27. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $92.50. The firm has a market cap of $4.60 billion, a P/E ratio of 15.19 and a beta of 0.56.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the company posted $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend was Friday, November 14th. Maximus’s dividend payout ratio (DPR) is 21.58%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.